Literature DB >> 7557859

The liver-spleen scan as a quantitative liver function test: correlation with liver severity at peritoneoscopy.

J C Hoefs1, F Wang, G Kanel, P Braunstein.   

Abstract

Sulfur colloid distribution on liver-spleen scan is determined by the perfused Kupffer cell mass. The perfused Kupffer cell mass is proportional to the perfused hepatocyte mass, but is less affected by acute changes in hepatocyte function. Thus, sulfur colloid distribution parameters (precisely measured by quantitative liver-spleen scan [QLSS]) may be an excellent test of the perfused hepatic mass. Although no gold standard exists for confirmation, a close correlation should exist between liver disease severity assessed at peritoneoscopy and sulfur colloid distribution. Peritoneoscopy severity (scored as total peritoneoscopy score [PS]; range, 0-5) was assessed in 76 patients who also had QLSS. Multivariate equation were generated to estimate liver disease severity from the QLSS. These were then applied prospectively in 20 consecutive patients to validate these equations. In 76 patients, 62 were evaluated because of chronic liver disease (CLD) and included those with micronodular (20) and macronodular (20) cirrhosis with various degrees of severity (Child's A, 16; B, 29; C, 17). Multivariate analysis yielded a number of combinations of QLSS parameters that correlated with peritoneoscopic severity. These equations were used to estimate liver disease severity. Estimates of liver disease severity (estimated PS [EPS]) correlated well with the PS in these 76 patients (r = .9064; r2 = .8216; P < .0001). Adding histological fibrosis to the QLSS parameters yields an equation for estimating PS that was even more effective (r = .9462; r2 = .8953; P < .001). However, validation of multivariate equations requires confirmation of their value in a second population.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7557859     DOI: 10.1016/0270-9139(95)90617-7

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.

Authors:  Gregory T Everson; Mitchell L Shiffman; John C Hoefs; Timothy R Morgan; Richard K Sterling; David A Wagner; Shannon Lauriski; Teresa M Curto; Anne Stoddard; Elizabeth C Wright
Journal:  Hepatology       Date:  2012-03-01       Impact factor: 17.425

2.  Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis C.

Authors:  John Carl Hoefs; Vikramjit S Aulakh; Bernard Joseph Ilagan
Journal:  Dig Dis Sci       Date:  2011-12-04       Impact factor: 3.199

3.  Factors affecting the quantitative liver-spleen scan in normal individuals.

Authors:  John C Hoefs; Muhammad Y Sheikh; Heather Guerrero; Norah Milne
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver.

Authors:  Dhritiman Chakraborty; Hejjaji Venkataramarao Sunil; Bhagwant Rai Mittal; Anish Bhattacharya; Baljinder Singh; Yogesh Chawla
Journal:  Indian J Nucl Med       Date:  2010-10

5.  Quantitative assessment of the presence and severity of cirrhosis in patients with hepatitis B using right liver lobe volume and spleen size measured at magnetic resonance imaging.

Authors:  Xiao-Li Chen; Tian-Wu Chen; Xiao-Ming Zhang; Zhen-Lin Li; Nan-Lin Zeng; Ting Li; Dan Wang; Jie Li; Zhi-Jia Fang; Hang Li; Jia Chen; Jun Liu; Guo-Hui Xu; Jing Ren; Jian-Lin Wu; Chun-Ping Li
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

6.  Quantitative evaluation of the reticuloendothelial system function with dynamic MRI.

Authors:  Ting Liu; Hoon Choi; Rong Zhou; I-Wei Chen
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.